<DOC>
	<DOCNO>NCT00821821</DOCNO>
	<brief_summary>The objective study assess safety , tolerability local tolerance , investigate plasma level terminal elimination half life MCI-186 , review routine clinical neurological assessment data MCI-186 subject acute ischemic stroke .</brief_summary>
	<brief_title>Safety Pharmacokinetics MCI-186 Subjects With Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Phenylmethylpyrazolone</mesh_term>
	<mesh_term>Antipyrine</mesh_term>
	<criteria>Full functional independence prior present stroke ( evidence premorbid modify Rankin Scale score 02 Clinical diagnosis acute stroke CT scan ruling intracranial hemorrhage Onset symptom within 124 hour commencement infusion study drug Measurable deficit NIHSS ( evidence score 315 ) Full consciousness ( i.e . score NIHSS item 1a=0 ) Written valid inform consent obtain subject his/her next kin legal representative subject fully conscious ( i.e . score NIHSS item 1a = 0 ) unable read and/or sign ICF , accordance National legislation local IRB requirement Subjects unlikely complete infusion investigational product and/or unlikely undergo active medical management period due severe clinical condition Subjects severe illness life expectancy le 6 month Body weight excess 120 kg Subjects receive rTPA thrombolytic ( e.g . urokinase , streptokinase , reteplase , tenecteplase ) within previous 24 hour Likelihood forbidden concomitant therapy vascular surgery , coronary artery bypass graft ( CABG ) , valve replacement , carotid endarterectomy ( CEA ) Evidence cerebral herniation Subjects confound neurological disease dementia Subjects CADASIL , Moya Moya , carotid dissection Subjects experience stroke within previous 3 month ( Note : subject recently experience TIA , whose premorbid mRS prior stroke 02 , allow enter study ) Evidence admission image test infarction involve &gt; 1/3 MCA territory , entire ACA territory involvement , internal carotid artery ( ICA ) occlusion without coexist separate occlusion middle cerebral artery ( difficulty distinguish chronic acute ICA lesion subject ) Pathology cerebral infarction admission image test ( e.g . ICH SAH , AV malformation , cerebral aneurysm , cerebral neoplasm ) Current previous know excessive alcohol use dependence Current know illicit drug use dependence Participation previous clinical study within 30 day Subjects unlikely able willing attend study followup visit Any condition opinion investigator deem subject ineligible inclusion Females pregnant intend become pregnant subject ( male female ) agree use effective contraception 3 month end treatment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>